A complete application in a minute — tailored resume and cover letter, ready to send.
Tempus AI, Inc. is seeking a specialist to provide daily oversight of a high‑throughput molecular workflow, ensuring rapid, high‑quality next‑generation sequencing data.
You will monitor QC, perform quality reviews, and supervise staff to maintain CLIA/CAP/NYSDOH compliance. You will also mentor technologists, schedule training, and leverage automation and robotics to streamline the sequencing pipeline while maintaining safety and regulatory standards.
Passionate about precision medicine and advancing the healthcare industry? Recent advancements in underlying technology have finally made it possible for AI to impact clinical care in a meaningful way. Tempus' proprietary platform connects an entire ecosystem of real-world evidence to deliver real-time, actionable insights to physicians, providing critical information about the right treatments for the right patients, at the right time.
Candidates must be able to work the assigned shift. Please note that shift assignment is based on technical level, experience, and current business needs. Current available shifts: Wed-Sat (2pm-12:30am)
CHI: $60,000-$80,000 The expected salary range may vary for other locations. Actual salary may vary based on qualifications and experience.
Tempus offers a full range of benefits, which may include incentive compensation, restricted stock units, medical and other benefits depending on the position.
We are an equal opportunity employer. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.
Tempus was founded in August of 2015 by Eric Lefkofsky, after his wife was diagnosed with Breast Cancer. Shortly after he founded the company in an effort to bring the power of technology and artificial intelligence to cancer care, he convinced Ryan Fukushima to join as the company’s first employee. Ryan and Eric began assembling a world class team, focused on building the first version of a platform capable of ingesting real time healthcare data in an effort to personalize diagnostics. We built the platform for oncology and have expanded it to neuropsychiatry, cardiology, infectious disease (through COVID), and radiology. Despite our rapid growth, our mission remains the same—to help make sure patients are on the right drug at the right time, so they can live longer and healthier lives. We’re looking for people who can change the world. Who question the status quo and don’t shy away from tough problems. For the builders who are never done building and the learners who are never done learning. We’re looking for passionate people with undying curiosity. Those who want to attack one of the most challenging problems mankind has ever faced. Head on.